MEDICAMEQPharmaceuticals
Medicamen Biotech Ltd — Balance Sheet
₹223.30
-4.88%
Medicamen Biotech Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 1.27 Cr | 1.27 Cr | 1.27 Cr | 1.22 Cr | — |
| Share Issued | 1.27 Cr | 1.27 Cr | 1.27 Cr | 1.22 Cr | — |
| Net Debt | 29.49 Cr | 16.33 Cr | 4.93 Cr | 21.97 Cr | — |
| Total Debt | 33.25 Cr | 31.11 Cr | 25.71 Cr | 25.80 Cr | — |
| Tangible Book Value | 212.04 Cr | 206.09 Cr | 192.52 Cr | 146.11 Cr | — |
| Invested Capital | 246.03 Cr | 238.10 Cr | 219.12 Cr | 172.27 Cr | — |
| Working Capital | 86.38 Cr | 75.04 Cr | 80.79 Cr | 50.35 Cr | — |
| Net Tangible Assets | 212.04 Cr | 206.09 Cr | 192.52 Cr | 146.11 Cr | — |
| Common Stock Equity | 212.78 Cr | 206.98 Cr | 193.41 Cr | 146.47 Cr | — |
| Total Capitalization | 216.51 Cr | 208.24 Cr | 194.28 Cr | 151.54 Cr | — |
| Total Equity Gross Minority Interest | 212.78 Cr | 206.98 Cr | 193.41 Cr | 146.47 Cr | — |
| Stockholders Equity | 212.78 Cr | 206.98 Cr | 193.41 Cr | 146.47 Cr | — |
| Other Equity Interest | 200.07 Cr | 187.77 Cr | 2.61 Cr | 134.25 Cr | — |
| Capital Stock | 12.71 Cr | 12.71 Cr | 12.65 Cr | 12.22 Cr | — |
| Total Liabilities Net Minority Interest | 84.10 Cr | 87.57 Cr | 85.10 Cr | 79.22 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 5.94 Cr | 3.01 Cr | 2.53 Cr | 6.53 Cr | — |
| Other Non Current Liabilities | 6000.00 | -1000.00 | — | 1000.00 | 1000.00 |
| Non Current Deferred Taxes Liabilities | -31000.00 | 0.00 | 0.00 | 0.00 | — |
| Long Term Debt And Capital Lease Obligation | 3.73 Cr | 1.26 Cr | 0.87 Cr | 5.07 Cr | — |
| Long Term Debt | 3.73 Cr | 1.26 Cr | 0.87 Cr | 5.07 Cr | — |
| Long Term Provisions | 2.20 Cr | 1.76 Cr | 1.66 Cr | 1.46 Cr | — |
| Current Liabilities | 78.17 Cr | 84.56 Cr | 82.57 Cr | 72.69 Cr | — |
| Other Current Liabilities | 1.93 Cr | 8.15 Cr | 3.98 Cr | 2.03 Cr | — |
| Current Debt And Capital Lease Obligation | 29.52 Cr | 29.86 Cr | 24.84 Cr | 20.72 Cr | — |
| Current Debt | 29.52 Cr | 29.86 Cr | 24.84 Cr | 20.72 Cr | — |
| Current Provisions | 0.81 Cr | 0.92 Cr | 0.69 Cr | 0.82 Cr | — |
| Payables | 45.90 Cr | 41.24 Cr | 47.23 Cr | 44.85 Cr | — |
| Total Tax Payable | 3.31 Cr | 4.06 Cr | 3.70 Cr | 4.26 Cr | — |
| Accounts Payable | 42.60 Cr | 36.70 Cr | 43.17 Cr | 43.30 Cr | — |
| Total Assets | 296.88 Cr | 294.55 Cr | 278.52 Cr | 225.69 Cr | — |
| Total Non Current Assets | 132.33 Cr | 134.96 Cr | 115.15 Cr | 102.66 Cr | — |
| Other Non Current Assets | 41.42 Cr | 39.37 Cr | 19.51 Cr | 8.82 Cr | — |
| Non Current Deferred Taxes Assets | 2.81 Cr | 2.51 Cr | 1.88 Cr | 0.50 Cr | — |
| Long Term Equity Investment | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Goodwill And Other Intangible Assets | 0.74 Cr | 0.90 Cr | 0.90 Cr | 0.36 Cr | — |
| Other Intangible Assets | 0.74 Cr | 0.90 Cr | 0.90 Cr | 0.36 Cr | — |
| Net PPE | 86.12 Cr | 90.95 Cr | 91.76 Cr | 92.12 Cr | — |
| Gross PPE | 86.12 Cr | 134.96 Cr | 128.86 Cr | 123.34 Cr | — |
| Construction In Progress | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other Properties | 86.12 Cr | 19.27 Cr | 17.33 Cr | 15.87 Cr | — |
| Current Assets | 164.55 Cr | 159.59 Cr | 163.36 Cr | 123.04 Cr | — |
| Other Current Assets | 26.66 Cr | 25.68 Cr | -1000.00 | 23.72 Cr | — |
| Inventory | 62.14 Cr | 59.38 Cr | 45.06 Cr | 27.01 Cr | — |
| Other Receivables | 3.09 Cr | 2.18 Cr | 2.51 Cr | 2.24 Cr | — |
| Accounts Receivable | 68.90 Cr | 55.26 Cr | 65.26 Cr | 63.22 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 3.76 Cr | 14.79 Cr | 20.78 Cr | 3.82 Cr | — |
| Cash And Cash Equivalents | 3.76 Cr | 14.79 Cr | 20.78 Cr | 3.82 Cr | — |
| Common Stock | 12.71 Cr | 12.71 Cr | 12.65 Cr | 12.22 Cr | — |
| Retained Earnings | — | 90.77 Cr | 82.54 Cr | 68.78 Cr | 55.11 Cr |
| Additional Paid In Capital | — | 102.31 Cr | 97.87 Cr | 67.70 Cr | 67.70 Cr |
| Tradeand Other Payables Non Current | — | 1.76 Cr | 1.66 Cr | — | — |
| Current Deferred Taxes Liabilities | — | 4.06 Cr | 3.70 Cr | 4.26 Cr | 4.60 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 0.92 Cr | 0.69 Cr | 0.82 Cr | 0.63 Cr |
| Other Payable | — | 4.43 Cr | 3.96 Cr | 1.47 Cr | 3.32 Cr |
| Dividends Payable | — | 0.11 Cr | 0.10 Cr | 0.08 Cr | 0.06 Cr |
| Non Current Prepaid Assets | — | 1.22 Cr | 1.11 Cr | 0.87 Cr | 0.78 Cr |
| Investmentin Financial Assets | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Accumulated Depreciation | — | -44.01 Cr | -37.10 Cr | -31.22 Cr | -25.56 Cr |
| Machinery Furniture Equipment | — | 77.42 Cr | 73.39 Cr | 69.50 Cr | 65.77 Cr |
| Buildings And Improvements | — | 37.32 Cr | 37.19 Cr | 37.03 Cr | 34.19 Cr |
| Land And Improvements | — | 0.94 Cr | 0.94 Cr | 0.94 Cr | 0.94 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 0.42 Cr | 0.31 Cr | 0.31 Cr | 0.41 Cr |
| Prepaid Assets | — | 7.13 Cr | 9.74 Cr | 8.16 Cr | 11.32 Cr |
| Other Inventories | — | 8.54 Cr | 8.66 Cr | 8.80 Cr | — |
| Finished Goods | — | 18.69 Cr | 17.05 Cr | 5.22 Cr | 2.51 Cr |
| Work In Process | — | 16.20 Cr | 0.90 Cr | 1.16 Cr | 0.52 Cr |
| Raw Materials | — | 15.95 Cr | 18.45 Cr | 11.83 Cr | 2.17 Cr |
| Taxes Receivable | — | 20.43 Cr | 19.70 Cr | 18.28 Cr | 20.40 Cr |
| Cash Equivalents | — | 13.92 Cr | 18.19 Cr | 2.99 Cr | 2.21 Cr |
| Cash Financial | — | 0.87 Cr | 2.59 Cr | 0.84 Cr | 1.68 Cr |
| Minority Interest | — | — | 0.12 Cr | 0.00 | — |
| Non Current Pension And Other Postretirement Benefit Plans | — | — | 1.66 Cr | 1.46 Cr | 1.16 Cr |
| Investment Properties | — | — | — | — | 0.00 |
| Goodwill | — | — | — | — | 0.00 |
| Allowance For Doubtful Accounts Receivable | — | — | — | — | 0.00 |
| Gross Accounts Receivable | — | — | — | — | 52.55 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Medicamen Biotech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.